Tanvex BioPharma
$0
1
+$0+0% Monday 00:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-1.629364023376
Actual EPS
N/A
Financials
-3,983.15%Profit Margin
Unprofitable2.14MRevenue
-85.18MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TANVF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.
Show more...
CEO
Country
KY
ISIN
KYG8676P1037
Listings
0 Comments
Share your thoughts
FAQ
What is Tanvex BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tanvex BioPharma stocks are traded under the ticker TANVF.
When is the next Tanvex BioPharma earnings date?▼
Tanvex BioPharma is going to release the next earnings report on May 08, 2026.
What were Tanvex BioPharma earnings last quarter?▼
TANVF earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.02 USD resulting in a -111.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tanvex BioPharma revenue for the last year?▼
Tanvex BioPharma revenue for the last year amounts to 2.14M USD.
What is Tanvex BioPharma net income for the last year?▼
TANVF net income for the last year is -85.18M USD.
When did Tanvex BioPharma complete a stock split?▼
Tanvex BioPharma has not had any recent stock splits.